Position in APYX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$819,874
+$176,707 QoQ
Shares Held
182,600
+4.8% QoQ
Ownership
0.433%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 67 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in APYX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $19,365,255 across 7 Medical Devices names. APYX ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
907,739 | $8,569,056 | |
| 2 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 3 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 4 | NVCR |
NovoCure Ltd
|
141,900 | $2,149,785 | |
| 5 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 6 | APYX |
Apyx Medical Corp
This page
|
182,600 | $819,874 | |
| 7 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in APYX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $819,874 | 182,600 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $643,167 | 174,300 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $330,750 | 94,500 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||